PEPTIDE COMPLEX INFLUENCE ON GENERAL WELL-BEING OF
PATIENTS WITH CEREBRAL ATHEROSCLEROSIS (percentagewise)
Study period — 2010–2012 Dosage regimens:
Location — Russia, Moscow, Moscow office Ventfort — 2 capsules a day for 3 months;
of the Peptides Research and Production Cerluten — 2 capsules a day for 3 months;
Center of Revitalization and Health
Svetinorm — 2 capsules a day for 3 months;
Actual enrollment — 1249 participants
Endoluten — 1 capsule a day (in the morning)
Age — 55–65 y.o. for 2 months.
Period of administration — 4 months
Parameter Before Standard Standard Standard
treatment, regimen, regimen and a regimen and a
complex: complex:
Ventfort®, Ventfort®,
Cerluten®, Cerluten®,
Svetinorm®,
Endoluten®,
1249
participants 281 participants 430 participants 538 participants
Headache 73,5 59,5 45,1* 29,8*
Sleep disorder 57,3 48,4 30,4 18,5*
Emotional lability 68,0 32,3 24,8 16,6
Memory 69,8 42,6 32,0* 14,2*
impairment
Difficulty focusing 57,2 43,8 29,5* 11,.3*
Rapid fatigability 75,6 64,0 32,3 12,9*
* Accurate in comparison with Group I (standard regimen).
89 // Health territory. PEPTIDES. Memory, intelligence and vision
Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.
Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.